beta(2)-adrenergic receptor agonists increase intracellular free Ca2+ concentration cycling in ventricular cardiomyocytes through p38 and p42/44 MAPK-mediated cytosolic phospholipase A(2) activation

Citation
S. Magne et al., beta(2)-adrenergic receptor agonists increase intracellular free Ca2+ concentration cycling in ventricular cardiomyocytes through p38 and p42/44 MAPK-mediated cytosolic phospholipase A(2) activation, J BIOL CHEM, 276(43), 2001, pp. 39539-39548
Citations number
47
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
276
Issue
43
Year of publication
2001
Pages
39539 - 39548
Database
ISI
SICI code
0021-9258(20011026)276:43<39539:BRAIIF>2.0.ZU;2-W
Abstract
We have recently reported that arachidonic acid mediates beta (2)-adrenergi c receptor (AR) stimulation of [Ca2+](i) cycling and cell contraction in em bryonic chick ventricular cardiomyocytes (Pavoine, C., Magne, S., Sauvadet, A., and Pecker, F. (1999) J. Biol. Chem.. 274, 628-637). In the present wo rk, we demonstrate that beta (2)-AR agonists trigger arachidonic acid relea se via translocation and activation of cytosolic phospholipase A. (cPLA(2)) and increase caffeine-releasable Ca2+ pools from Fura-2-loaded cells. We a lso show that beta (2)-AR agonists trigger a rapid and dose-dependent phosp horylation of both p38 and p42/44 MAPKs. Translocation and activation of eP LA(2), as well as Ca2+ accumulation in sarcoplasmic reticulum stores sensit ive to caffeine and amplification of [Ca2+](i) cycling in response to beta (2)-AR agonists, were blocked by inhibitors of the p38 or p42/44 MAPK pathw ay (SB203580 and PD98059, respectively), suggesting a role of both MAPK sub types in beta (2)-AR stimulation. In contrast, beta (1)-AP. stimulation of [Ca2+](i) cycling was rather limited by the MAPKs, clearly proving the dive rgence between beta (2)-AR and beta (1)-AR signaling systems. This study pr esents the first evidence for the coupling of beta (2)-AR to cardiac ePLA(2 ) and points out the key role of the MAPK pathway in the intracellular sign aling elicited by positive inotropic beta (2)-AR agonists in heart.